KOL Perspectives: Upadacitinib for Rheumatoid Arthritis

KOL Perspectives: Upadacitinib for Rheumatoid Arthritis


This KOL Insight briefing focuses on perceptions of novel upadacitinib data in RA.

The briefing includes analysis of KOL opinion on the following topic areas -

  • Efficacy & safety of upadacitinib in the SELECT COMPARE trial (csDMARD-IR patients)
  • Efficacy & safety of upadacitinib as a monotherapy in SELECT MONOTHERAPY trial (MTX-IR patients)
  • Views on dose response for upadacitinib
Key Highlights
  • Majority of KOLs had a positive opinion of upadacitinib’s efficacy, particularly vs. adalimumab, in the SELECT COMPARE trial
  • Most KOLs had a favorable opinion of Week 12 upadacitinib data vs. adalimumab from the SELECT COMPARE trial
  • KOLs appeared unsure of upadacitinib’s comparative efficacy vs. other JAK inhibitors, with many citing the need for head-to-head studies.
  • The insight briefing is based on Sociable Pharma’s analysis of primary research with our RA key opinion leaders (KOLs)
  • In total, we conducted interviews with 10 KOLs: Five Europe-based & five US-based
  • Interviews performed in Q2 2018
  • KOL data is analyzed to produce: Charts summarizing KOL opinions
  • Chart call-outs of key information & details
  • KOL quotes
  • Summary of KOL reporting trends
  • Insight from Sociable Pharma's analysts.
Reasons to buy
  • Combines Qualitative & semi-quantitative insight from key opinion leaders on Upadacitinib for Rheumatoid Arthritis
  • Includes insight & recommendations from our disease-specific healthcare analysts
  • Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of rheumatoid arthritis
  • Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion.

Executive Summary
Research Panel Composition
Results & Implications

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook